Longboard Pharmaceuticals (LBPH)
NASDAQ:LBPH
US Market
Holding LBPH?
Track your performance easily

Longboard Pharmaceuticals (LBPH) Financial Statements

273 Followers

Longboard Pharmaceuticals Financial Overview

Longboard Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.163; its P/E ratio is -13.55; Longboard Pharmaceuticals is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.79M$ -18.11M$ -15.57M$ -12.82M$ -14.83M
EBITDA$ -19.93M$ -18.11M$ -15.57M$ -13.03M$ -15.20M
Net Income Common Stockholders$ -21.89M$ -14.99M$ -15.03M$ -12.82M$ -15.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 304.87M$ 321.04M$ 48.50M$ 56.02M$ 63.05M
Total Assets$ 312.90M$ 327.67M$ 50.70M$ 58.86M$ 66.22M
Total Debt$ 3.86M$ 3.98M$ 475.00K$ 502.00K$ 589.00K
Net Debt$ -301.01M$ -317.06M$ -48.02M$ -55.51M$ -62.46M
Total Liabilities$ 18.30M$ 13.96M$ 9.77M$ 6.82M$ 8.12M
Stockholders Equity$ 294.60M$ 313.71M$ 40.92M$ 52.04M$ 58.11M
Cash Flow-
Free Cash Flow$ -19.13M$ -15.18M$ -11.03M$ -13.29M$ -13.46M
Operating Cash Flow$ -19.13M$ -15.18M$ -11.03M$ -13.29M$ -13.46M
Investing Cash Flow$ -20.69M$ -230.92M$ -1.56M$ 11.75M$ 7.96M
Financing Cash Flow$ 21.00K$ 286.40M$ 3.01M$ 5.95M$ -125.00K
Currency in USD

Longboard Pharmaceuticals Earnings and Revenue History

Longboard Pharmaceuticals Debt to Assets

Longboard Pharmaceuticals Cash Flow

Longboard Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis